The noninferiority trial of patients at risk for both bleeding and stroke, in a surprise turn, found standard care to be ...

Both olive oil and vegetable oil can help improve certain heart disease risk factors, but they provide these benefits in ...

Personalized vitamin D supplementation -- often requiring 5,000 IU of vitamin D each day -- did prove to have secondary ...

Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will present new late-breaking data highlighting the clinical and economic ...

"These findings suggest that while PCSK9 inhibitors are safe and effective at lowering lipids, their impact on early vascular remodeling in heart transplant recipients may be limited -- at least ...

2025 Financial Outlook Heartflow expects total revenue for the full year 2025 to be in the range of $173.0 million to $173.5 million, representing year-over-year growth of approximately 37.5% to 38.0% ...

Among patients with LVO-related AIS undergoing EVT, general anesthesia is linked to better 90-day recovery and functional independence vs sedation.

IR uses the blood vessel network in the body as almost like a subway map. We can get on and off at different stops to access different parts of the body and treat disease. IR is the intersection of ...

For more than two decades, Bracco has made education a cornerstone of progress in radiology. In 2024 alone, Bracco's educational programs reached over 100,000 healthcare professionals worldwide, ...

New study results from a large international all-comer population of percutaneous coronary intervention (PCI) candidates ...

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announced results from four Late-Breaking ...

October 29, 2025 3-Year data from the largest global trial to date using Class I, Level A iFR in heart attack patients shows treating additional stenoses in the same procedure showed no significant ...